Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32


Shaping Striated Muscles with Ubiquitin Proteasome System in Health and Disease.

Hnia K, Clausen T, Moog-Lutz C.

Trends Mol Med. 2019 Sep;25(9):760-774. doi: 10.1016/j.molmed.2019.05.008. Epub 2019 Jun 21. Review.


The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer.

Spinner CA, Lamsoul I, Métais A, Febrissy C, Moog-Lutz C, Lutz PG.

Cancer Immunol Res. 2019 Aug;7(8):1332-1344. doi: 10.1158/2326-6066.CIR-18-0562. Epub 2019 Jun 7.


Asb2α-Filamin A Axis Is Essential for Actin Cytoskeleton Remodeling During Heart Development.

Métais A, Lamsoul I, Melet A, Uttenweiler-Joseph S, Poincloux R, Stefanovic S, Valière A, Gonzalez de Peredo A, Stella A, Burlet-Schiltz O, Zaffran S, Lutz PG, Moog-Lutz C.

Circ Res. 2018 Mar 16;122(6):e34-e48. doi: 10.1161/CIRCRESAHA.117.312015. Epub 2018 Jan 26.


Substrates of the ASB2α E3 ubiquitin ligase in dendritic cells.

Spinner CA, Uttenweiler-Joseph S, Metais A, Stella A, Burlet-Schiltz O, Moog-Lutz C, Lamsoul I, Lutz PG.

Sci Rep. 2015 Nov 5;5:16269. doi: 10.1038/srep16269.


The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation.

Thottakara T, Friedrich FW, Reischmann S, Braumann S, Schlossarek S, Krämer E, Juhr D, Schlüter H, van der Velden J, Münch J, Patten M, Eschenhagen T, Moog-Lutz C, Carrier L.

J Mol Cell Cardiol. 2015 Oct;87:214-24. doi: 10.1016/j.yjmcc.2015.08.020. Epub 2015 Sep 3.


Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?

Lamsoul I, Uttenweiler-Joseph S, Moog-Lutz C, Lutz PG.

Biochimie. 2016 Mar;122:339-47. doi: 10.1016/j.biochi.2015.08.003. Epub 2015 Aug 4. Review.


Phosphorylation of serine 323 of ASB2α is pivotal for the targeting of filamin A to degradation.

Zakaria R, Lamsoul I, Uttenweiler-Joseph S, Erard M, Monsarrat B, Burlet-Schiltz O, Moog-Lutz C, Lutz PG.

Cell Signal. 2013 Dec;25(12):2823-30. doi: 10.1016/j.cellsig.2013.09.011. Epub 2013 Sep 15.


ASB2α regulates migration of immature dendritic cells.

Lamsoul I, Métais A, Gouot E, Heuzé ML, Lennon-Duménil AM, Moog-Lutz C, Lutz PG.

Blood. 2013 Jul 25;122(4):533-41. doi: 10.1182/blood-2012-11-466649. Epub 2013 Apr 30.


Functional and structural insights into ASB2alpha, a novel regulator of integrin-dependent adhesion of hematopoietic cells.

Lamsoul I, Burande CF, Razinia Z, Houles TC, Menoret D, Baldassarre M, Erard M, Moog-Lutz C, Calderwood DA, Lutz PG.

J Biol Chem. 2011 Sep 2;286(35):30571-81. doi: 10.1074/jbc.M111.220921. Epub 2011 Jul 7.


The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation.

Bello NF, Lamsoul I, Heuzé ML, Métais A, Moreaux G, Calderwood DA, Duprez D, Moog-Lutz C, Lutz PG.

Cell Death Differ. 2009 Jun;16(6):921-32. doi: 10.1038/cdd.2009.27. Epub 2009 Mar 20.


ASB2 targets filamins A and B to proteasomal degradation.

Heuzé ML, Lamsoul I, Baldassarre M, Lad Y, Lévêque S, Razinia Z, Moog-Lutz C, Calderwood DA, Lutz PG.

Blood. 2008 Dec 15;112(13):5130-40. doi: 10.1182/blood-2007-12-128744. Epub 2008 Sep 17.


Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis.

Heuzé ML, Lamsoul I, Moog-Lutz C, Lutz PG.

Blood Cells Mol Dis. 2008 Mar-Apr;40(2):200-10. Epub 2007 Oct 4. Review.


Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

Mourali J, Bénard A, Lourenço FC, Monnet C, Greenland C, Moog-Lutz C, Racaud-Sultan C, Gonzalez-Dunia D, Vigny M, Mehlen P, Delsol G, Allouche M.

Mol Cell Biol. 2006 Aug;26(16):6209-22.


Role of the subcellular localization of ALK tyrosine kinase domain in neuronal differentiation of PC12 cells.

Gouzi JY, Moog-Lutz C, Vigny M, Brunet-de Carvalho N.

J Cell Sci. 2005 Dec 15;118(Pt 24):5811-23. Epub 2005 Nov 29.


Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.

Moog-Lutz C, Degoutin J, Gouzi JY, Frobert Y, Brunet-de Carvalho N, Bureau J, Créminon C, Vigny M.

J Biol Chem. 2005 Jul 15;280(28):26039-48. Epub 2005 May 10.


JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells.

Moog-Lutz C, Cavé-Riant F, Guibal FC, Breau MA, Di Gioia Y, Couraud PO, Cayre YE, Bourdoulous S, Lutz PG.

Blood. 2003 Nov 1;102(9):3371-8. Epub 2003 Jul 17.


Metastatic lymph node 64 (MLN64), a gene overexpressed in breast cancers, is regulated by Sp/KLF transcription factors.

Alpy F, Boulay A, Moog-Lutz C, Andarawewa KL, Degot S, Stoll I, Rio MC, Tomasetto C.

Oncogene. 2003 Jun 12;22(24):3770-80.


Signaling revisited in acute promyelocytic leukemia.

Lutz PG, Moog-Lutz C, Cayre YE.

Leukemia. 2002 Oct;16(10):1933-9. Review.


ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.

Guibal FC, Moog-Lutz C, Smolewski P, Di Gioia Y, Darzynkiewicz Z, Lutz PG, Cayre YE.

J Biol Chem. 2002 Jan 4;277(1):218-24. Epub 2001 Oct 26.


PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.

Moog-Lutz C, Peterson EJ, Lutz PG, Eliason S, Cavé-Riant F, Singer A, Di Gioia Y, Dmowski S, Kamens J, Cayre YE, Koretzky G.

J Biol Chem. 2001 Jun 22;276(25):22375-81. Epub 2001 Apr 11.


Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acid.

Lutz PG, Houzel-Charavel A, Moog-Lutz C, Cayre YE.

Blood. 2001 Apr 15;97(8):2449-56.


Myeloblastin is a granulocyte colony-stimulating factor-responsive gene conferring factor-independent growth to hematopoietic cells.

Lutz PG, Moog-Lutz C, Coumau-Gatbois E, Kobari L, Di Gioia Y, Cayre YE.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1601-6.


Proteinase 3 mRNA expression is induced in monocytes but not in neutrophils of patients with cystic fibrosis.

Just J, Moog-Lutz C, Houzel-Charavel A, Canteloup S, Grimfeld A, Witko-Sarsat V, Cayre YE.

FEBS Lett. 1999 Sep 3;457(3):437-40.


Genomic organization and chromosomal localization of mouse proteinase 3 (Myeloblastin).

Belaaouaj A, Moog-Lutz C, Just J, Houzel-Charavel A, Shapiro SD, Cayre Y.

Mamm Genome. 1999 Mar;10(3):210-2.


Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions.

Schreiber V, Moog-Lutz C, Régnier CH, Chenard MP, Boeuf H, Vonesch JL, Tomasetto C, Rio MC.

Mol Med. 1998 Oct;4(10):675-87.


MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis.

Watari H, Arakane F, Moog-Lutz C, Kallen CB, Tomasetto C, Gerton GL, Rio MC, Baker ME, Strauss JF 3rd.

Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8462-7.


MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas.

Moog-Lutz C, Tomasetto C, Régnier CH, Wendling C, Lutz Y, Muller D, Chenard MP, Basset P, Rio MC.

Int J Cancer. 1997 Apr 10;71(2):183-91.


Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.

Bièche I, Tomasetto C, Régnier CH, Moog-Lutz C, Rio MC, Lidereau R.

Cancer Res. 1996 Sep 1;56(17):3886-90.


Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma.

Régnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Basset P, Rio MC.

J Biol Chem. 1995 Oct 27;270(43):25715-21.


Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains.

Tomasetto C, Moog-Lutz C, Régnier CH, Schreiber V, Basset P, Rio MC.

FEBS Lett. 1995 Oct 16;373(3):245-9.


Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22.

Moog-Lutz C, Bouillet P, Régnier CH, Tomasetto C, Mattei MG, Chenard MP, Anglard P, Rio MC, Basset P.

Int J Cancer. 1995 Oct 9;63(2):297-303.


Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17.

Tomasetto C, Régnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC.

Genomics. 1995 Aug 10;28(3):367-76.


Supplemental Content

Loading ...
Support Center